Crossmark

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

Published Online: 2014-11-27

Published Print: 2015-02

Authors

Tsukahara, T

Iwase, N

Kawakami, K

Iwasaki, M

Yamamoto, C

Ohmine, K

Uchibori, R

Teruya, T

Ido, H

Saga, Y

Urabe, M

Mizukami, H

Kume, A

Nakamura, M

Brentjens, R

Ozawa, K
License Information

Text and Data Mining valid from 2014-11-27

Version of Record valid from 2014-11-27
More Information

Article History

Received: 31 March 2014

Revised: 29 September 2014

Accepted: 21 October 2014

First Online: 27 November 2014

Competing interests

: The authors declare no conflict of interest.

Document is current